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Abstract
Cholestasis causes hepatocyte death, possibly due to mitochondrial injury. This study investigated
whether NIM811, an inhibitor of the mitochondrial permeability transition (MPT), attenuates
cholestatic liver injury in vivo. Cholestasis was induced in mice by bile duct ligation (BDL). NIM811
was gavaged (20 mg/kg) before BDL and daily (10 mg/kg) afterwards. Mitochondrial depolarization,
cell death and MPT onset were assessed by intravital confocal/multiphoton microscopy of rhodamine
123 (Rh123), propidium iodide (PI) and calcein. After BDL, serum alanine aminotransferase (ALT),
hepatic necrosis and apoptosis all increased. NIM811 decreased ALT, necrosis and apoptosis by 60
to 86%. In vehicle-treated mice at 6 h after BDL, viable hepatocytes with depolarized mitochondria
were 18/high power field (hpf), and non-viable cells were ∼1/hpf, showing that depolarization
preceded necrosis. Calcein entered mitochondria after BDL, indicating MPT onset in vivo. NIM811
decreased depolarization by 72%, prevented calcein entry into mitochondria and blocked release of
cytochrome c. Hepatic TNFα, TGF-β1 and procollagen α1(I) mRNA, α-smooth muscle actin, and
Sirius red staining for collagen increased after BDL but were not different in vehicle- and NIM811-
treated mice. Taken together, NIM811 decreased cholestatic necrosis and apoptosis but did not block
fibrosis, indicating that the MPT plays an important role in cholestatic cell death in vivo.
Introduction
Cholestasis represents an interruption of bile secretion developing either acutely or chronically.
Cholestatic liver disease results from hepatitis, complications of surgery, trauma, intravenous
feeding, tumors, gallstones, certain medications and idiopathic, genetic and metabolic diseases,
such as primary biliary cirrhosis and sclerosing cholangitis (Poupon, et al., 2000).
Accumulation of bile acids (BA) induces injury due to the toxicity of hydrophobic BA to
hepatocytes and cholangiocytes (Kass, 2006). Toxic BA cause both necrotic and apoptotic cell
death (Fickert, et al., 2005;Gujral, et al., 2004;Faubion, et al., 1999). Chronic cholestatic liver
diseases eventually lead to liver cirrhosis, which is a leading indication for liver transplantation.
How cholestasis induces liver injury and fibrosis remains controversial. Cytotoxic bile salts
trigger hepatocyte apoptosis partly by ligand-independent activation of CD95 (Fas) death
receptors (Faubion, et al., 1999). In isolated hepatocytes, exposure to hydrophobic BA causes
Address correspondence to: Dr. Zhi Zhong, Department of Pharmaceutical and Biomedical Sciences, Medical University of South
Carolina, 280 Calhoun Street, PO Box 250140, Charleston, SC 29425. Phone: (843) 792-2163; Fax: (843) 792-1617; email:
zhong@musc.edu.
#Part of this research was reported as an abstract in Gastroenterology, 130; A-759, 2006.
NIH Public Access
Author Manuscript
J Pharmacol Exp Ther. Author manuscript; available in PMC 2009 December 1.
Published in final edited form as:













mitochondrial production of reactive oxygen species (ROS) (Rolo, et al., 2003;Sokol, et al.,
1995). Cytotoxic BA also induce ROS formation by activation of NADPH oxidase (Reinehr
and Haussinger, 2007). ROS can trigger opening of permeability transition (PT) pores in the
mitochondrial inner membrane that nonspecifically transport aqueous solutes up to a molecular
weight of about 1500 Da (Halestrap and Brennerb, 2003;Kantrow, et al., 2000). Onset of the
MPT collapses the mitochondrial membrane potential, leading to failure of ATP synthesis,
release of proapoptotic cytochrome c, and necrotic and apoptotic cell death (Zamzami, et al.,
1996;Kim, et al., 2003). Antioxidants and cyclosporin A (CsA), a specific inhibitor of the MPT
(Halestrap and Davidson, 1990), protect cultured hepatocytes from BA-induced loss of
viability (Yerushalmi, et al., 2001;Gores, et al., 1998;Rolo, et al., 2003), implicating a role for
a ROS-dependent MPT in BA hepatotoxicity. Mitochondria isolated from human livers also
generate ROS and undergo MPT onset in response to BA (Sokol, et al., 2005). However,
whether MPT pore opening occurs in vivo during cholestasis to contribute to cholestatic liver
injury and liver fibrosis remains to be determined.
N-Methyl-4-isoleucine cyclosporin (NIM811) is a non-immunosuppressive derivative of CsA
that inhibits the MPT in cultured hepatocytes, isolated liver mitochondria, and liver grafts after
transplantation in mice and rats (Waldmeier, et al., 2002;Zhong, et al., 2007;Theruvath, et al.,
2008). NIM811 is equipotent to CsA for inhibition of onset of the MPT in cultured cells and
isolated mitochondria (Waldmeier, et al., 2002;Theruvath, et al., 2008). NIM811 also
suppresses collagen production and proliferation of cultured hepatic stellate cells (HSC)
(Kohjima, et al., 2007). Study of mitochondrial dysfunction and the MPT in vivo has been
difficult. However, advances in intravital confocal/multiphoton microscopy now permit
assessment of mitochondrial function and inner membrane permeability in livers of living
animals (Theruvath, et al., 2008;Zhong, et al., 2007). Since the MPT plays an important role
in both necrosis and apoptosis (Kim, et al., 2003), and since MPT onset occurs in hepatocytes
after exposure to BA, we used intravital confocal/multiphoton microscopy to evaluate the role
of the MPT in cholestatic liver injury in vivo and to determine whether blockade of the MPT
with NIM811 prevents cholestatic cell death and liver fibrosis.
Methods
Animals
Male BALB/c mice (8 - 9 weeks) were gavaged with N-Methyl-4-isoleucine cyclosporin
(NIM811, Novartis Pharma Ltd., Switzerland, 20 mg/kg) or an equal volume of vehicle
containing 8.3% polyethoxylated castor oil (Sigma, St. Louis, MO) and 8.3% ethanol at 2 h
before surgery. Mice underwent bile duct ligation (BDL) or sham-operation under ether
anesthesia. Briefly, the common bile duct was double ligated near the liver and transected
between ligatures. NIM811 (10 mg/kg) or vehicle was gavaged daily after surgery. All animals
received humane care in compliance with institutional guidelines. Animal protocols were
approved by the Institutional Animal Care and Use Committee.
Clinical Chemistry and Histology
At times indicated in the figure legends, mice were anesthetized with pentobarbital (80 mg/kg,
i.p.), and blood was collected from inferior vena cava. Livers were harvested and slides were
prepared as described elsewhere (Zhong, et al., 2003). In sections stained with hematoxylin
and eosin (H+E), ten random fields per slide were captured in a blinded manner using a
Universal Imaging Image-1/AT image acquisition and analysis system (West Chester, PA)
with an Axioskop 50 microscope (Carl Zeiss, Inc., Thornwood, NY) and a 10× objective lens.
Necrotic areas were quantified by image analysis using IP Lab 3.7v software (BD Biosciences,
Rockville, MD) by dividing necrotic areas by total cellular area of the images. Some slides
were stained with 0.1% Sirius red (Polysciences Inc., Warrington, PA) and fast green FCF
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(Sigma Chemical, St. Louis, MO) to evaluate liver fibrosis, and Sirius red-positive area was
quantified as described (Zhong, et al., 2003). In other experiments, liver tissue was frozen and
stored at -80°C for later mRNA analysis. Serum alanine transaminase (ALT) was measured
using a kit from Pointe Scientific (Uncoln Park, MI).
Intravital Confocal and Multiphoton Microscopies
Rhodamine123 (Rh123, Sigma, St. Louis, MO) was used to monitor mitochondrial polarization
after cholestasis. Rh123, a cationic fluorophore, is taken up by polarized mitochondria and is
released when mitochondria depolarize (Emaus, et al., 1986). Propidium iodide (PI) was used
to label nuclei of non-viable cells. At 6 h after BDL or sham-operation, mice were anesthetized
with pentobarbital (80 mg/kg, i.p.) and connected to a small animal ventilator via a respiratory
tube (20-gauge catheter) inserted into the trachea. Rh123 (2 μmol/mouse) and PI (0.04 μmol/
mouse) were infused via polyethylene (PE10) tubing inserted into the carotid artery over 10
min. Preliminary studies showed that carotid injections yielded reliable and uniform labeling
of hepatocytes by fluorophores without disturbance to hepatic blood supply.
MPT pore opening was assessed using calcein acetoxymethyl ester (calcein-AM), which is
cleaved by esterases in the cytosol to form green-fluorescing calcein free acid. Since
mitochondria are normally impermeant to calcein, calcein is retained in the cytosol, leaving
mitochondria as nonfluorescent voids (Nieminen, et al., 1995). These voids disappear after
onset of the MPT as calcein, a 623 Da solute, enters the mitochondrial matrix space through
PT pores (Nieminen, et al., 1995). Due to the expense of calcein-AM and the potential for its
de-esterification prior to entry into the liver, calcein-AM (1 mg/mouse) was injected slowly
into the rectal vein at 6 h after BDL or sham-operation. To prevent biliary excretion of calcein,
an anion channel inhibitor, bromosulphthalein (6.6 μmol/mouse), was injected into the rectal
vein 5 min before calcein-AM.
For intravital confocal microscopy, laparotomized mice were put in a prone position over a
coverslip mounted on the stage of a CARV spinning disk confocal microscopic system (ATTO
Bioscience, Rockville, MD) with a 40× water immersion objective lens (Zeiss C-Apochromat,
1.2 NA) using excitation wavelengths of 488 and 555 nm, respectively, and a multiwavelength
emission filter to detect Rh123 and PI fluorescence. The respirator was turned off for ∼5 sec
to eliminate breathing movement artifacts during image acquisition. Ten random fields were
imaged per mouse. Bright green punctate Rh123 fluorescence represented cells with polarized
mitochondria, whereas dimmer diffuse Rh123 fluorescence represented cells with depolarized
mitochondria. Nonviable PI positive cells, indicated by red nuclear fluorescence, were counted
in the same fashion. Image analysis was performed in a blinded manner.
Green fluorescence of calcein was detected in some mice by intravital multiphoton microscopy
using a Zeiss LSM 510 NLO laser scanning confocal/multiphoton microscope (Thornwood,
NY) and a 63× C-apo N.A. 1.2 water-immersion objective lens. Two-photon excitation of
calcein was performed with 720 nm light from a Coherent Chameleon Ultra laser and emission
was collected through a 500-550 nm bandpass emission filter. Images of approximately 10
random liver fields were collected from each mouse.
Immunohistochemical Detection of α-Smooth Muscle Actin, and Cytochrome c
α-Smooth muscle actin (αSMA) was detected immunohistochemically as described elsewhere
(Zhong, et al., 2003). Immunohistochemical staining of cytochrome c was performed using an
InnoGenex™ Mouse-on-Mouse Iso-IHC kit (InnoGenex, San Ramon, CA) according to the
manufacturer's instructions after applying primary antibody at 1:200 (Santa Cruz Biotec, Santa
Cruz, CA) at room temperature for 30 min.
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Apoptosis was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end
labeling (TUNEL) using an In Situ Cell Death Detection Kit (Zhong, et al., 2007). TUNEL-
positive and negative cells were counted in a blinded manner in 10 randomly selected fields
using a 40× objective lens.
Activation of caspase-3 was assessed by Western blotting using an antibody specific for
cleaved caspase-3. Liver tissue was harvested at 3 days after BDL when TUNEL peaked and
was homogenized in 0.1% Triton-X100 buffer containing protease and phosphatase inhibitors.
The extract was centrifuged at 14,000 × g for 15 min at 4°C, and aliquots of supernatant (40
μg of protein) were separated on 4-12% SDS-PAGE gels, transferred onto nitrocellulose
membranes and immunoblotted with primary antibodies (Affinity Bioreagents Golden, CO)
specific for cleaved caspase-3 and actin (Cell Signaling Technology, Danvers, MA; 1:1000
and 1:3000, respectively, over night at 4°C). Horseradish peroxidase-conjugated secondary
antibodies were applied, and detection was by chemiluminescence (ECL, Amersham).
Detection of TNFα, TGF-β1 and Procollagen α1(I) mRNA by Quantitative Real Time PCR
Total RNA from liver tissue was isolated with Trizol (Invitrogen, Grand Island, NY) according
to the manufacturer's protocol. Single stranded cDNAs were synthesized from RNA (2 μg)
isolated from liver tissue using a Bio-Rad iScript cDNA Synthesis kit (Bio-Rad, Hercules,
CA). Primer sets were designed and synthesized by Integrated DNA technologies (IDT,
Coralville, IA). The primer sequences are listed in Table 1. PCR reactions were performed in
triplicate with a reaction mixture containing 2× IQ™SYBR Supermix (Bio-Rad), cDNA
template, and 0.1 nM of the forward and reverse primers. Real-time PCR was conducted using
an iCycler iQ Multi-Color Real-Time PCR Detection System (Bio-Rad, Hercules, CA). iTaq
DNA polymerase was activated at 95°C for 10 min, and 40 cycles of amplification at 95°C for
30 sec and 62°C for 30 sec were performed. Data were analyzed with MyiQ software. The
abundance of mRNAs was normalized against hypoxanthine phospho-ribosyl-transferase
(HPRT) housekeeping gene using the ΔΔCt method.
Statistical Analysis
Groups were compared using ANOVA plus Student-Newman-Keuls posthoc test. Data shown
are means ± S.E.M. (4 to 5 livers per group). Differences were considered significant at p<0.05.
Results
NIM811 Decreases Liver Injury after Cholestasis
Histology revealed normal liver architecture after sham-operation (Fig. 1, upper left). After
BDL, focal necrosis developed within 1 day (data not shown) and became more marked after
3 days (Fig. 1, middle left). Necrotic areas accounted for 11% of liver sections at 1 day after
BDL, which increased to 20% after 3 days and 28% after 14 days (Fig. 2A). NIM811 decreased
necrotic areas to 0.5%, 3% and 8% at 1, 3 and 14 days, respectively (Fig. 1, lower left and Fig.
2A).
Serum ALT, an indicator of liver injury, averaged 58 U/L (Fig. 2B) after sham-operation and
was not altered by NIM811 treatment. After BDL, ALT increased to 2280 U/L after 1 day,
decreasing to 1150 U/L and 1600 U/L after 3 and 14 days (Fig. 2B). When mice were treated
with NIM811, peak ALT after BDL was decreased by 60% and remained lower than the
untreated group 2 weeks after BDL (Fig. 2B).
Apoptosis in liver sections was detected by TUNEL (Fig. 1, right column). TUNEL was rare
in livers from sham-operated mice (0.13 cells/hpf, Fig. 1 upper right and Fig. 2C). TUNEL did
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not increase at 1 day after BDL but increased markedly to 18 cells/hpf and 17 cells/hpf at 3
and 14 days after BDL, respectively (Fig. 1, middle right and Fig. 2C). Increased TUNEL was
almost completely blocked by NIM811 (Fig. 1, lower right and Fig. 2C). Occurrence of
apoptosis was further confirmed by activation of caspase-3. Cleaved caspase-3 was barely
detectable after sham-operation but increased markedly at 3 days after BDL (Fig. 2D). This
effect was largely blocked by NIM811 (Fig. 2D).
Taken together, these data show that NIM811 protects against hepatocellular injury and death
at the early and late stages of cholestasis. Cell killing after BDL involved both necrosis and
apoptosis with necrosis occurring earlier than apoptosis. Specific inhibition of the MPT with
NIM811 effectively prevented necrosis and apoptosis caused by cholestasis.
Mitochondrial Permeability Transition Occurs after Bile Duct Ligation: Prevention by NIM811
Previous studies showed that mitochondria of isolated hepatocytes generate ROS when
exposed to hydrophobic BA, followed by MPT onset (Rolo, et al., 2003;Sokol, et al., 1995).
Since mitochondrial depolarization is an immediate consequence of the MPT, we investigated
if mitochondrial depolarization occurs after cholestasis in vivo. At 6 h after BDL, Rh123, a
green-fluorescing fluorophore taken up by polarized mitochondria, and PI, a red-fluorescing
fluorophore staining nuclei of non-viable cells, were infused, and intravital confocal
fluorescent microscopy was performed. Overlays of green and red images allowed
identification of viable cells with polarized mitochondria (no red nuclear fluorescence,
intracellular punctate mitochondrial green fluorescence), viable cells with depolarized
mitochondria (no red fluorescence, no or diffuse green fluorescence) and non-viable cells (red
nuclear fluorescence). In non-viable cells, mitochondria were consistently depolarized.
In sham-operated mice, green Rh123 fluorescence was punctate in virtually all hepatocytes,
indicating mitochondrial polarization (Fig. 3. upper left), and red PI labeling of nuclei was
undetectable (Fig. 3. upper left). At 6 h after BDL, many hepatocytes contained depolarized
mitochondria that did not accumulate Rh123 (Fig. 3, upper right,). Other hepatocytes showed
diffuse but relatively bright Rh123 fluorescence, possibly indicating the recent depolarization
of mitochondria and release of mitochondrial Rh123 into the cytosol. Occasionally, some
parenchymal and non-parenchymal cells (NPC) were also labeled with PI (<1 cell/hpf, Fig. 3,
upper right). Most hepatocytes with depolarized mitochondria excluded PI, whereas PI-labeled
hepatocytes never contained polarized mitochondria. These results suggest that at 6 h after
BDL, mitochondrial depolarization occurred in many hepatocytes and that mitochondrial
depolarization preceded hepatocyte death. After NIM811 treatment, mitochondrial
depolarization decreased from 18 cells/hpf after vehicle to 5 cells/hpf (Fig. 3, lower panels).
PI-labeled cells were not different between the NIM811-treated and untreated groups, since
cell death was rare at this early stage of cholestasis.
Calcein was used to monitor onset of the MPT by intravital multiphoton microscopy. Calcein
loaded into the cytosol but did not permeate mitochondria. Thus, calcein fluorescence outlined
individual mitochondria as dark voids in the hepatocytes of sham-operated mice (Fig. 4. upper
left). These voids disappeared at 6 h after BDL, indicating movement of calcein into
mitochondria through opened PT pores after onset of the MPT (Fig. 4. middle left). This loss
of calcein holes cannot be due to premature cell death since cell death would cause loss of all
calcein fluorescence. NIM811 effectively prevented calcein permeation into mitochondria in
vivo after BDL (Fig. 4. lower left). These findings showed directly that NIM811-sensitive
mitochondrial inner membrane permeabilization occurred in vivo due to cholestasis.
Rehman et al. Page 5













NIM811 Prevents Cytochrome c Release after Cholestasis
The MPT causes large amplitude mitochondrial swelling, outer membrane rupture and release
of cytochrome c from the intermembrane space into the cytosol, which can trigger caspase
activation and apoptosis (Kantrow, et al., 2000;Zamzami, et al., 1996). Accordingly, we
investigated cytochrome c release after BDL with and without NIM811 treatment. Cytochome
c detected immunohistochemically was punctate in hepatocytes of liver slides from sham-
operated mice consistent with mitochondrial localization (Fig. 4, upper right). After BDL,
cytochome c staining became diffuse, indicating release of cytochome c into the cytosol (Fig.
4, middle right). Release of cytochome c after BDL was largely prevented by NIM811.
NIM811 Does Not Prevent Inflammatory and Profibrogenic Cytokine Formation after Bile Duct
Ligation
Cell death after cholestasis may cause inflammation that subsequently leads to liver fibrosis.
The proinflammatory cytokine, TNFα, plays an important role in liver fibrosis (Friedman,
1999). Therefore, we investigated whether NIM811 prevents TNFα expression after BDL.
TNFα mRNA increased 11-fold at 3 days after BDL and 38-fold at 2 weeks in vehicle-treated
mice (Fig. 5A). Surprisingly, NIM811 did not prevent these increases of TNFα expression after
BDL despite protection against cell death (Fig. 5A).
TGF-β increases in a variety of inflammatory processes and is an important promoter of hepatic
fibrosis (Friedman, 1999). Accordingly, we detected TGF-β expression after BDL. TGF-β1
mRNA increased 2-fold at 3 days after BDL and 10-fold after 2 weeks in vehicle-treated mice
(Fig. 5B). Again, NIM811 did not prevent increases of TGF-β1 expression after BDL (Fig.
5B).
NIM811 Does Not Prevent Hepatic Fibrosis after Bile Duct Ligation
To evaluate the effects of NIM811 on liver fibrosis after BDL, liver sections were stained with
Sirius red for collagen. No fibrosis was observed in livers from sham-operated mice (Fig. 6A,
upper left). By contrast, hepatic fibrosis developed within 2 weeks after BDL (Fig. 6A, middle
left). Sirius red-positive area increased from 1% in sham-operated mice to 21% at 2 weeks
after BDL (Fig. 6B left). When mice treated with NIM811 were subjected to BDL, histology
revealed similar fibrosis as vehicle treatment (Fig. 6A, lower left). Sirius red-positive area was
23% at 2 weeks after BDL (Fig. 6B left).
Hepatic collagen gene expression was evaluated by quantitative real time PCR for procollagen
α1(I) mRNA. At 2 weeks after BDL, procollagen α1(I) mRNA increased 19-fold compared to
sham-operated mice (Fig. 6B right). Treatment with NIM811 did not prevent the increase of
procollagen α1(I) mRNA expression caused by cholestasis (Fig. 6B right).
NIM811 Does Not Prevent Stellate Cell Activation after Bile Duct Ligation
Activated HSCs are the major source of matrix proteins in diseased liver (Friedman, 2008).
Accordingly, we evaluated αSMA, an indicator of HSC activation, by immunohistochemical
staining after BDL. In livers from sham-operated mice, small amounts of αSMA were detected
in the smooth muscle and endothelium of blood vessels (Fig. 6A, upper right). At 2 weeks after
BDL, αSMA increased markedly in perisinusoidal cells (Fig. 6A, middle right), indicating
activation of HSCs. After BDL, αSMA increased to the same extent in livers of NIM811-treated
mice as after vehicle treatment (Fig. 6A, lower right). Taken together, these data show that
NIM811 treatment did not prevent proinflammatory cytokine formation, fibrosis and HSC
activation caused by cholestasis.
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Mitochondrial Permeability Transition Plays an Important Role in Cholestasis-Induced Liver
Injury in vivo
In cholestasis, BA accumulate to cause hepatic injury. Mechanisms of BA-induced cell death
are not fully understood. BA toxicity is not due to a detergent effect (Guicciardi and Gores,
2002). Several studies show that cytotoxic BA trigger hepatocyte apoptosis by activation of
death receptors (Fickert, et al., 2005;Faubion, et al., 1999). Despite evidence of Fas and TRAIL-
dependent apoptotic signaling in cholestatic liver injury, recent studies suggest that necrosis
is the predominant form of cell death after BDL (Fickert, et al., 2005;Gujral, et al., 2004).
Oxidative stress and mitochondrial injury may also play a role in BA-induced cell death.
Oxidative stress occurs in biliary obstructed rats (Pastor, et al., 1997;Parola, et al., 1996) and
isolated hepatocytes and mitochondria exposed to hydrophobic BA (Rolo, et al., 2003;Sokol,
et al., 1995). Antioxidants and overexpression of mitochondrial Mn-SOD decreased cell death
after BDL (Zhong, et al., 2003;Zhong, et al., 2002). ROS not only directly damage
macromolecules but also alter signal transduction. For example, BA cause activation of
NADPH oxidase generating a ROS signal activating Yes-, JNK-, and EGFR-dependent CD95
(Fas) tyrosine phosphorylation and formation of the death-inducing signaling complex
(Reinehr and Haussinger, 2007). ROS also trigger opening of PT pores (Kantrow, et al.,
2000). Increased mitochondrial calpain-like protease activity during cholestasis might also
induce MPT onset (Gores, et al., 1998).
The MPT is an important mechanism leading to mitochondrial dysfunction and cell death
(Lemasters, 2005). Despite extensive work, the exact molecular composition of PT pores
remains unclear. In one model, PT pores are composed of the voltage-dependent anion channel
(VDAC), the adenine nucleotide translocator (ANT), cyclophilin D (CypD) and various
ancillary proteins (Martinou and Green, 2001). However, recent studies using ANT and VDAC
isoform knockout mice challenge this model (Kokoszka, et al., 2004). An alternative model is
that PT pores are formed by aggregation of misfolded and damaged membrane proteins in
association with CypD and other molecular chaperones (He and Lemasters, 2002), and recent
studies confirm that CypD is an important regulator of PT pore activity (Baines, et al., 2005).
MPT onset leads to collapse of the mitochondrial membrane potential, failure of ATP
production, and necrotic cell death (Zamzami, et al., 1996;Kim, et al., 2003). Moreover, the
MPT causes large amplitude swelling and release of cytochrome c into the cytosol, triggering
apoptosis (Kantrow, et al., 2000;Zamzami, et al., 1996).
Both CsA and bongkrekic acid, inhibitors of the MPT, protect cultured hepatocytes from BA-
induced cell death (Yerushalmi, et al., 2001;Gores, et al., 1998). Mitochondria isolated from
cholestatic rats also exhibit disruption of mitochondrial calcium homeostasis by BA, which
might increase susceptibility of mitochondria to calcium-induced MPT onset (Rolo, et al.,
2002). In addition, human liver mitochondria undergo the MPT in response to hydrophobic
BA (Sokol, et al., 2005). These data show that BA cause MPT onset in vitro. However, whether
cholestasis-induced MPT onset occurs in live animals has never been determined. Using
intravital confocal/multiphoton microscopy, here we show directly that mitochondrial
depolarization and inner membrane permeabilization do occur in vivo after BDL (Fig. 3). This
mitochondrial depolarization is caused by MPT onset, as indicated by entry of calcein into
mitochondria after BDL (Fig. 4) and blockade of this permeabilization with the consequent
depolarization by the specific MPT inhibitor, NIM811 (Fig. 3 and 4). Importantly, MPT onset
and mitochondrial depolarization preceded necrosis and apoptosis (Fig. 3 and 4). Moreover,
inhibition of MPT onset substantially attenuated cytochrome c release from mitochondria (Fig.
4). These data show clearly that the MPT plays an important role in cholestatic liver injury in
vivo.
Rehman et al. Page 7













CsA at high therapeutic serum concentrations (0.17-0.8 μM) partially inhibits the canalicular
bile salt excretion pump (BSEP) and the basolateral Na+/taurocholate co-transporting
polypeptide (NTCP) (Mita, et al., 2006). Effects of NIM811 on BSEP and NTCP have not yet
been reported, and a contribution of inhibition of bile salt transport to NIM811 cytoprotection
after BDL cannot be excluded. However in the present work, neither partial inhibition of BSEP
nor NTCP would be expected to prevent hepatocellular accumulation of toxic BA, since BSEP
inhibition would only serve to increase intracellular BA concentration and since incomplete
inhibition of NTCP would not prevent equilibration of BA accumulation inside hepatocytes
with the plasmalemmal Na+ gradient. Future studies will be needed to better characterize the
effects of NIM811 on hepatocellular BA transport.
Previous work establishes a role for death receptor activation in cholestatic liver injury (Fickert,
et al., 2005;Gujral, et al., 2004;Faubion, et al., 1999), but controversy still exists as to how
death receptor activation leads to mitochondrial dysfunction, cytochrome c release and cell
death. Some studies support a mechanism in which caspase 8 activation causes tBid formation,
which in turn activates Bax/Bak-dependent permeabilization of the outer membrane and
cytochrome c release (Zhao, et al., 2003). Other findings indicate that death receptor activation
causes the MPT, an inner membrane event, which leads to either ATP depletion-dependent
necrosis or caspase-dependent apoptosis (Lemasters, 2005). Our findings here suggest that the
MPT is the predominant event precipitating phenotypes of both apoptotic and necrotic cell
death in cholestasis, at least in the mouse model of BDL. Future studies need to assess role of
MPT in Fas-dependent injury, such as Jo-2 antibody stimulation.
MPT Inhibition Does Not Prevent Hepatic Fibrosis after Bile Duct Ligation
Chronic cholestatic liver diseases cause liver cirrhosis (Poupon, et al., 2000). Fibrogenesis in
liver is likely an active wound-healing process regulated by cytokines, chemokines and
additional signals like ROS (Friedman, 2008). Hepatocytes release fibrogenic lipid peroxides
(Novo, et al., 2006), and lipid peroxidation associated with hepatocyte necrosis is considered
a classical inflammatory and fibrogenic stimulus (Friedman, 2008). In addition, apoptotic
hepatocytes can release cytoplasmic fragments that are fibrogenic towards cultured HSCs
(Canbay, et al., 2003). Therefore, we expected that prevention of cell injury by NIM811 would
alleviate subsequent liver fibrosis. Strikingly, although inhibition of the MPT by NIM811
effectively prevented cholestatic necrosis and apoptosis of hepatocytes through the whole
cholestatic process (Figs 1-2), NIM811 did not attenuate liver fibrosis after BDL (Fig. 6).
The dissociation of cytoprotection of NIM811 from antifibrogenesis suggests the cell death
may not play an essential role in cholestatic liver fibrosis. Although mechanisms of liver
fibrosis are not well understood, the concept is generally accepted that prolonged liver injury
triggers activation of HSCs and hepatic recruitment of inflammatory cells, effects likely
mediated by inflammatory cytokines (Friedman, 1999). Therefore, we investigated if NIM811
altered inflammatory cytokine production. Expression of TNFα, a major proinflammatory
cytokine that is important in liver fibrosis (Friedman, 1999), increased after BDL, but this effect
was not attenuated by NIM811 (Fig. 5). Similarly, NIM811 did not block expression of TGF-
β, a major profibrogenic cytokine (Friedman, 1999), after BDL (Fig. 5). These unexpected
findings suggest that inflammatory processes in cholestasis are not due to cell death but elicited
mainly by direct effects of BA or other excretion products accumulated during cholestasis on
inflammatory cytokine-producing cells, such as Kupffer cells and HSCs.
Activation of HSCs is a critical step in hepatic fibrogenesis (Friedman, 2008). Activated HSCs
produce pro-fibrogenic cytokines, such as TGF-β, synthesize collagen (Parsons, et al.,
2007;Friedman, 1999;Kisseleva and Brenner, 2007) and secrete inhibitors of matrix-degrading
enzymes (Kisseleva and Brenner, 2007). Therefore, we investigated whether NIM811
prevented HSC activation. As expected, αSMA, a marker of HSC activation, dramatically
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increased after BDL (Fig. 6). Although NIM811 inhibits proliferation of cultured hepatic HSCs
in vitro (Kohjima, et al., 2007), NIM811 had no effect on αSMA production in vivo (Fig. 6).
Thus, prevention of cell death did not block HSC activation after cholestasis consistent with
the conclusion that excess BA or other excretion products accumulated in cholestasis either
activate HSCs directly or stimulate other NPC (i.e., Kupffer cells, endothelial cells and
cholangiocytes) to release inflammatory or fibrogenic cytokines and growth factors that
activate HSCs. BA maintain HSC in an activated state (Brady, et al., 1996). Other substances
that accumulate during cholestasis (e.g., bilirubin, cholesterol, phospholipids, metals) may also
stimulate liver fibrosis. For example, accumulated iron might stimulate ROS production to
cause HSC activation. Moreover, high cholesterol activates HSCs and induces liver fibrosis
(Kainuma, et al., 2006). Future studies will be needed to better characterize these profibrotic
mechanisms in cholestasis that are independent of hepatocellular death.
BDL represents acute and complete cholestasis that leads to overt cholangiocyte reactions.
Whether independence of liver fibrosis from cell death as observed in acute BDL also occurs
in cholestasis of more chronic onset or in other liver fibrosis models (e.g., CCl4, thioacetamide,
ethanol) is still unknown and will also need to be the subject of future studies.
Taken together, the present study shows that the MPT occurs in vivo in hepatocytes during
cholestasis and plays an essential role in necrotic and apoptotic hepatocellular death. NIM811,
a specific inhibitor of the MPT, effectively prevents cell killing; but does not prevent
subsequent liver fibrosis. Liver fibrosis is possibly elicited by direct effects of BA on HSCs,
cholangiocytes and other NPC.
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Fig. 1. NIM811 Mitigates Hepatic Necrosis and Apoptosis after Bile Duct Ligation
Livers were harvested 3 days after sham-operation (Sham) or BDL. H+E staining (left
column) was performed to evaluate necrosis. TUNEL (right column) was performed to
evaluate apoptosis. Arrows identify necrotic areas. The white bar is 100 μm and the black bar
is 50 μm.
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Fig. 2. NIM811 Decreases Liver Injury after Bile Duct Ligation
Livers and blood were collected at 0, 1, 3 and 14 days after BDL. Necrosis (A) was quantified
by image analysis of 10 random fields per liver. Blood was collected for ALT measurement
(B). TUNEL-positive cells were counted in a blinded manner in 10 randomly selected fields
using a 40× objective lens (C). *, p<0.05 vs BDL of corresponding time point (n = 4-5 per
group). Caspase-3 activation 3 days after BDL was evaluated by Western analysis of cleaved
caspase-3, as illustrated in blot images representative of 4 experiments per group (D).
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Fig. 3. Protection of NIM811 Against Mitochondrial Depolarization after Bile Duct Ligation
At 6 h after surgery, Rh123 and PI were infused, and intravital confocal microscopy was
performed. Bar is 20 μm. Viable cells with polarized mitochondria, viable cells with
depolarized mitochondria and non-viable cells were counted in 10 random fields of each liver
(low right panel). a, p<0.05 vs sham; b, p<0.05 vs BDL (n = 4-5 per group).
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Fig. 4. NIM811 Prevents Onset of the Mitochondrial Permeability Transition and Cytochrome C
Release after Bile Duct Ligation
At 6 h after surgery, calcein-AM was infused, and intravital multiphoton microscopy was
performed (left column). Bar is 5 μm. In the right column, cytochome c was detected by
immunohistochemistry. Bar is 20 μm.
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Fig. 5. NIM811 Does Not Prevent TNFα and TGF-β Expression after Bile Duct Ligation
Livers were harvested 3 days and 2 weeks after sham-operation (Sham) or BDL. TNFα and
TGF-β1 mRNAs were detected by quantitative real time PCR. The abundance of TNFα and
TGF-β mRNAs was normalized against HPRT using the ΔΔCt method. A.U., arbitrary unit.
a, p<0.05 vs sham; b, p<0.05 vs BDL (n = 4 per group).
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Fig. 6. NIM811 Does Not Prevent Hepatic Fibrosis and Stellate Cell Activation after Bile Duct
Ligation
Livers were harvested 2 weeks after sham-operation (Sham) or BDL. In A, Sirius red staining
(left column) and immunohistochemical staining for α–smooth muscular actin (αSMA, right
column) were performed. Rows are: upper, sham-operation; middle, BDL; lower, BDL plus
NIM811 (NIM) treatment. The white and black bars are 200 μm and 50 μm, respectively. In
B left, Sirius red-positive area was quantified by image analysis. In B right, procollagen α1
(I) mRNA was detected by quantitative real time PCR. The abundance of procollagen α1(I)
mRNA was normalized against HPRT using the ΔΔCt method. A.U., arbitrary unit. a, p<0.05
vs sham; b, p<0.05 vs BDL (n = 4 per group).
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Table 1
Primers for Real-Time PCR





Procollagen α1(I) Forward 5′-GAACAGGGTGTTCCTGGAGA-3′
Reverse 5′-GGAAACCTCTCTCGCCTCTT-3′
Hypoxanthine phospho-ribosyl-transferase Forward 5′-GCTTTCCCTGGTTAAGCAGTACA-3′
Reverse 5′-AAACTTGTCTGGAATTTCAAATC-3′
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